<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="43465">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01807325</url>
  </required_header>
  <id_info>
    <org_study_id>IRB8317</org_study_id>
    <nct_id>NCT01807325</nct_id>
  </id_info>
  <brief_title>RNA Sequencing of Solid and Cystic Lesions of the Pancreas</brief_title>
  <official_title>RNA Sequencing of Solid and Cystic Lesions of the Pancreas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oregon Health and Science University</source>
  <oversight_info>
    <authority>United States: Investigational Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The nature of cysts and solid masses in the pancreas can be difficult to diagnose. They may
      be benign, precancerous, or cancer. Current tests such as cytology (looking under a
      microscope) and tumor markers do not always give us the answer. The investigators are
      looking for genetic markers on biopsy specimens from the pancreas that will give us a better
      test for diagnosis. This study is only for diagnosing these lesions. The investigators are
      not treating any patients.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Gene classifier that will classify lesions as benign or malignant with 95% certainty</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Pancreas Cyst</condition>
  <condition>Pancreas Mass</condition>
  <arm_group>
    <arm_group_label>pancreas cysts and solid masses</arm_group_label>
    <description>patents referred for solid and cystic lesions of the pancreas who will have a biopsy for usual medical care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreas biopsy</intervention_name>
    <description>patients who are already having a pancreas biopsy will be invited to enroll. After obtaining enough tissue for usual medical care, we will divert some tissue for the study.</description>
    <arm_group_label>pancreas cysts and solid masses</arm_group_label>
    <other_name>RNA sequencing of pancreas tissue</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      pancreas biopsies
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        adult, nonpregnant patients referred for endoscopic ultrasound to evaluate solid or cystic
        lesion of the pancreas.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  greater than 18 years old,

          -  not pregnant,

          -  referred for endoscopic ultrasound,

          -  have a cyst or mass of the pancreas needing diagnosis.

        Exclusion Criteria:

          -  pregnant,

          -  less than age 18,

          -  no mass or cyst found.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Providence St Vincent Hospital</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <lastchanged_date>March 7, 2013</lastchanged_date>
  <firstreceived_date>March 6, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oregon Health and Science University</investigator_affiliation>
    <investigator_full_name>Sarah Rodriguez</investigator_full_name>
    <investigator_title>physician</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatic Cyst</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatin</mesh_term>
    <mesh_term>Pancrelipase</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
